The clinical outcome of Toxoplasma gondii infections in those individuals whose immune system is under-developed or compromised can be severe and ultimately fatal. The ability of tachyzoites to convert to bradyzoites (tissue cysts) is considered to be the underlying cause of Toxoplasma-encephalitis in HIV-1 infection. The molecular events regulating tachyzoite to bradyzoite transition are critical to the course of this disease. Recently, the applicants have demonstrated that tachyzoites emerging from sporozoite infected cells undergo a regulated change to a longer cell cycle that precedes their spontaneous differentiation to the bradyzoite form. The shift to a slower replicative cycle is essential to the tachyzoite developmental program since slow growth is consistently correlated with bradyzoite differentiation. In this proposal the applicants will investigate the mechanisms that regulate the tachyzoite cell cycle in order to ultimately identify new targets for Toxoplasma prevention.
In specific aim I, they will define the major phases of the tachyzoite cell cycle (G1, S, G2+M) and the unique process of cytokinesis associated with apical complex formation.
Specific aim II will address the essential mechanisms that regulate tachyzoite growth. Through genetic complementation of ts cell cycle mutants, they will identify and then characterize genes required for cell cycle progression.
In specific aim III they will introduce thymidine kinase into fast and slow growing VEG strain in order to determine the cell cycle phases which are altered during growth shift. Finally in specific aim IV they will compare the mRNA expression of fast and slow growing TK+ VEG tachyzoites in order to identify molecular changes associated with these distinct cell cycle types.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI044600-03
Application #
6349883
Study Section
Special Emphasis Panel (ZRG5-AARR-4 (01))
Program Officer
Rogers, Martin J
Project Start
1999-02-01
Project End
2003-01-31
Budget Start
2001-02-01
Budget End
2002-01-31
Support Year
3
Fiscal Year
2001
Total Cost
$160,643
Indirect Cost
Name
Montana State University Bozeman
Department
Veterinary Sciences
Type
Schools of Earth Sciences/Natur
DUNS #
City
Bozeman
State
MT
Country
United States
Zip Code
59717
Gubbels, Marc-Jan; White, Michael; Szatanek, Tomasz (2008) The cell cycle and Toxoplasma gondii cell division: tightly knit or loosely stitched? Int J Parasitol 38:1343-58
Conde de Felipe, Magnolia M; Lehmann, Margaret M; Jerome, Maria E et al. (2008) Inhibition of Toxoplasma gondii growth by pyrrolidine dithiocarbamate is cell cycle specific and leads to population synchronization. Mol Biochem Parasitol 157:22-31
Taylor, S; Barragan, A; Su, C et al. (2006) A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314:1776-80
Radke, Jay R; Donald, Robert G; Eibs, Amy et al. (2006) Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development. PLoS Pathog 2:e105
Kvaal, Christopher A; Radke, Jay R; Guerini, Michael N et al. (2002) Isolation of a Toxoplasma gondii cyclin by yeast two-hybrid interactive screen. Mol Biochem Parasitol 120:187-94
Striepen, Boris; White, Michael W; Li, Catherine et al. (2002) Genetic complementation in apicomplexan parasites. Proc Natl Acad Sci U S A 99:6304-9
Guerini, M N; Que, X; Reed, S L et al. (2000) Two genes encoding unique proliferating-cell-nuclear-antigens are expressed in Toxoplasma gondii. Mol Biochem Parasitol 109:121-31
Radke, J R; Guerini, M N; White, M W (2000) Toxoplasma gondii: characterization of temperature-sensitive tachyzoite cell cycle mutants. Exp Parasitol 96:168-77
Radke, J R; White, M W (1999) Expression of herpes simplex virus thymidine kinase in Toxoplasma gondii attenuates tachyzoite virulence in mice. Infect Immun 67:5292-7